Biovail

Biovail Corporation is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company's therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease (including Type II diabetes). Biovail drives business growth by commercializing these products both directly through its own sales and marketing divisions and/or through strategic partners. Biovail's core competency lies in the development and large-scale manufacturing of pharmaceutical products incorporating oral drug-delivery technologies. Biovail has a broad portfolio of proprietary drug-delivery technologies that represent the foundation upon which the Company's strategy is based. Product candidates that meet a rigorous screening process are considered for addition to the Company's development pipeline. To this end, development efforts are currently ongoing for a number of pipeline products, including a once-daily formulation of carvedilol, novel formulations of bupropion and venlafaxine, separate combination products involving bupropion and tramadol, and a number of feasibility, or earlier-stage programs.

Contact Details: 7150 Mississauga Road Mississauga L5N 8M5 Canada Tel: 905.286.3000 Fax: 905.286.3050 Email: ir@biovail.com WWW: www.biovail.com/

Loading...

Recent Publications by Biovail:
Determination of carryover and contamination for mass spectrometry-based chromatographic assays. The Third American Association of Pharmaceutical Scientists/Food and Drug...	6th February, 2008	Biovail Contract Research,	AAPS J. 2007 Nov 2;9(3):E353-60. DOI Direct Link
Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain. BACKGROUND: Tramadol ER* is a once-daily oral analgesic for management of...	15th December, 2007	Clinical Development, Biovail Technologies, Ltd., Bridgewater, NJ, USA.	Curr Med Res Opin. 2007 Oct;23(10):2531-42. DOI Direct Link
Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites. OBJECTIVE: To assess bioequivalence of two once-daily formulations of...	19th September, 2007	Biovail Technologies Ltd., Chantilly, VA 20151, USA.	Curr Med Res Opin. 2007 Jul;23(7):1593-604. DOI Direct Link
A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study. AIMS: To assess the feasibility of administering at the same time low...	18th December, 2004	The Quebec Heart and Lung Institute, Laval Hospital, Quebec, Canada.	Br J Clin Pharmacol. 2004 Sep;58(3):288-97. DOI Direct Link
Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration. A novel diltiazem HCl extended-release (ER) tablet formulation was...	27th February, 2004	Department of Pharmacokinetics and Toxicology, Biovail Technologies, Ltd.,	J Clin Pharmacol. 2003 Oct;43(10):1149-57. DOI Direct Link
→View more Biovail research publications.

BioNews Results for Biovail:
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development	SmartBrief:  Aug 23 2008 7:31AM Matching: biovail
Biovail Appoints Peggy Mulligan Chief Financial Officer	SmartBrief:  Aug 23 2008 7:31AM Matching: biovail
Biovail names new CFO	Datamonitor:  Aug 23 2008 2:25AM Matching: biovail
Biovail Names New Chief Financial Officer	National Post:  Aug 23 2008 12:58AM Matching: biovail
Biovail names Peggy Mulligan CFO	Clinical Lab Products:  Aug 22 2008 4:48PM Matching: biovail
Promote your company here: BioNewsCast - Press Release Distribution	→View more Biovail news.

Biovail Patents:
US Patent No.	Title
7241805	Modified release formulations of a bupropion salt
6967218	Pravastatin pharmaceutical formulations and methods of their use
6893661	Controlled release formulations using intelligent polymers
6733789	Multiparticulate bisoprolol formulation
6517886	Positive hydration method of preparing confectionery and the resulting product
→View more Biovail patents.

Biovail (BVF) Financial information Links from Barchart
BVF Quote from from Barchart.com
BVF Chart from from Barchart.com
BVF Profile from from Barchart.com
BVF Opinion from from Barchart.com
→View more Biovail finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 479 times since April 2007, the link to the organisation's website has been followed 63 times

Recent Search Terms used to find this page: biovail uk formulation scientist uk | Modified release formulations of a bupropion salt | Biovail Technologies Bridgewater NJ | diltiazem | determination of carryover and contamination for mass spectrometry-based chromatographic assays | biovail va | Biovail 2007 | novel technologies in tablet formulation | Direct link Company in Mississauga | t | .

Search for more companies in Mississauga

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biovail